IEH Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that IEH Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $28.78M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $21.52M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $19.14M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $24.27M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $34.72M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $32.15M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $28.41M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $23.47M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $20.13M | Jul 13, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Mar 31, 2017 | $20.13M | Jul 14, 2017 |
| FY2016 | Mar 25, 2016 | $19.36M | Jul 14, 2017 |
| FY2015 | Mar 27, 2015 | $16.39M | Jul 8, 2016 |
| FY2014 | Mar 28, 2014 | $15.43M | Jul 10, 2015 |
| FY2013 | Mar 29, 2013 | $13.33M | Jul 11, 2014 |
| FY2012 | Mar 30, 2012 | $13.29M | Jul 10, 2013 |
| FY2011 | Mar 25, 2011 | $13.82M | Jul 9, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $999.0K | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | ($2.92M) | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | ($6.50M) | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $1.44M | Apr 22, 2024 |
| FY2022 | Dec 31, 2021 | ($205.0K) | Apr 22, 2024 |
| FY2022 | Sep 30, 2021 | ($242.2K) | Apr 22, 2024 |
| FY2022 | Jun 30, 2021 | $2.34M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $2.03M | Apr 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.04M | Apr 22, 2024 |
| FY2022 | Sep 30, 2020 | $1.40M | Apr 22, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $574.9K | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | ($3.76M) | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | ($5.81M) | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | ($938.9K) | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $2.58M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $1.42M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $7.68M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $4.35M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $2.78M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $3.12M | Jul 14, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.15M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $6.16M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $5.52M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $5.04M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $6.90M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $6.01M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $4.01M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $4.01M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $3.75M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $3.05M | Jul 14, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.88M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | ($1.91M) | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | ($3.79M) | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $1.41M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $4.84M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $1.68M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $6.02M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $1.15M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $52.4K | Jul 13, 2018 |
| FY2014 | Mar 27, 2015 | $436.0K | Jul 10, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $532.4K | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $347.2K | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $545.5K | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $2.65M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $759.9K | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $969.4K | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $840.3K | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $377.0K | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $595.4K | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $507.4K | Jul 14, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $27.20M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $26.91M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $29.20M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $35.87M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $36.07M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $27.05M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $26.08M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $19.41M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $16.58M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $14.70M | Jul 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.09M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $5.11M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $4.88M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $5.05M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $7.07M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $1.78M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $3.82M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $2.33M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $1.52M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $1.12M | Jul 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $23.11M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $21.80M | Jun 12, 2025 |
| FY2025 | Mar 31, 2023 | $24.32M | Jun 12, 2025 |
| FY2024 | Mar 31, 2022 | $30.82M | Jun 14, 2024 |
| FY2022 | Mar 31, 2021 | $29.00M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $25.27M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $22.27M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $17.07M | Oct 8, 2020 |
| FY2019 | Mar 31, 2017 | $15.05M | Mar 20, 2020 |
| FY2017 | Mar 25, 2016 | $13.58M | Jul 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $14.81M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $13.81M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $16.73M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | $23.23M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | $21.79M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | $19.76M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | $18.44M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | $13.28M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | $11.29M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | $10.81M | Jul 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $10.54M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $6.14M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $8.34M | Jun 14, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | (1) | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | (2) | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | 0 | Apr 22, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Jun 30, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Apr 22, 2024 |
| FY2022 | Sep 30, 2020 | 0 | Apr 22, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | (1) | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | (2) | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | 0 | Apr 22, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Jun 30, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | 0 | Apr 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Apr 22, 2024 |
| FY2022 | Sep 30, 2020 | 0 | Apr 22, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 2.39M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | 2.38M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | 2.37M | Jun 14, 2024 |
| FY2022 | Mar 31, 2022 | 2.37M | Apr 22, 2024 |
| FY2022 | Mar 31, 2021 | 2.37M | Apr 22, 2024 |
| FY2022 | Mar 31, 2020 | 2.37M | Apr 22, 2024 |
| FY2019 | Mar 29, 2019 | 2.32M | Oct 8, 2020 |
| FY2019 | Mar 30, 2018 | 2.30M | Mar 20, 2020 |
| FY2017 | Mar 31, 2017 | 2.30M | Jul 13, 2018 |
| FY2016 | Mar 25, 2016 | 2.30M | Jul 14, 2017 |